Articles By Rob Wright, Chief Editor 2011-2021
-
![BIO 2018 panel_450x300]( "How To Broker Strategic Alliances Between International Biopharma Stakeholders")
How To Broker Strategic Alliances Between International Biopharma Stakeholders8/2/2018A summary from the BIO conference panel “Don’t Be Foreign To Foreign Affairs — How To Broker Biopharma Strategic Alliances And Partnerships Between International Stakeholders”
-
![Are You Up To Speed On AI Terminology?]( "Are You Up To Speed On AI Terminology?")
Are You Up To Speed On AI Terminology?7/24/2018A primer on AI terminology for the upcoming August feature with Sanofi’s Medical Function EVP, Ameet Nathwani, M.D.
-
![The Drug Pricing Dilemma, Pfizer, And President Trump]( "The Drug Pricing Dilemma, Pfizer, And President Trump")
The Drug Pricing Dilemma, Pfizer, And President Trump7/13/2018An op-ed regarding Pfizer’s drug-pricing actions, President Trump, and the potential impact on the biopharmaceutical industry’s image.
-
![At The End Of The Day — And Other Phrases That Could Be Used Less]( "At The End Of The Day — And Other Phrases That Could Be Used Less")
At The End Of The Day — And Other Phrases That Could Be Used Less7/9/2018A review of buzzwords and phrases that should be used less in the world of business.
-
![Dermira_Thomas Wiggans_450x300]( "Dermatology — A Growth Opportunity For Those Willing To Risk Colossal Failure")
Dermatology — A Growth Opportunity For Those Willing To Risk Colossal Failure7/5/2018Tom Wiggans, founder, chairman, and CEO of Dermira, provides an overview of the dermatology market, the impetus for founding Dermira, and transparently shares his experience regarding his company’s Phase 3 clinical trial failures.
-
![Jeff Jonas3_Sage_450x300]( "Sage Therapeutics — Sitting On The Brink Of CNS Breakthroughs")
Sage Therapeutics — Sitting On The Brink Of CNS Breakthroughs7/5/2018Jeff Jonas, M.D., CEO of Sage Therapeutics, discusses how the company is preparing to launch a new CNS product likely to change the paradigm for how postpartum depression is treated.
-
![outlook image]( "What Will The Next 10 Years Bring For Biopharma?")
What Will The Next 10 Years Bring For Biopharma?7/5/2018The biopharma industry has changed significantly during the past 10 years, and so has Life Science Leader. What will the next decade have in store for issues such as drug pricing and new therapeutic advances?
-
![Did BIO 2018 Do More Than Make History In Boston?]( "Did BIO 2018 Do More Than Make History In Boston?")
Did BIO 2018 Do More Than Make History In Boston?6/14/2018BIO 2018 does more than make business meeting history, but facilitates personal connections that can lead toward doing better business.
-
![Miriam alone BIO 2018]( "BIO 2018 — A View Through The Eyes Of An Aspiring Biomedical Engineer")
BIO 2018 — A View Through The Eyes Of An Aspiring Biomedical Engineer6/12/2018Miriam Massaad, a biomedical engineering student at Boston University, shares her experiences as a first-time attendee at the 2018 BIO International Convention and Conference in Boston.
Rob Wright
Rob Wright was chief editor of Life Science Leader magazine from 2011-2021. Prior to joining the publication, he spent nearly 20 years in the pharmaceutical industry. During his industry career, Wright conducted well over 1,000 presentations and roundtable discussions, including the facilitation of FDA-mandated clinical training programs for hundreds of licensed healthcare providers. He has chaired, moderated, and served as a speaker at industry and academic conferences, and served as co-chair for the 2015 and 2018 BIO International conference’s educational planning committee. Wright’s 500+ published articles have appeared in peer-reviewed academic journals, B2B magazines and online publications. He received a B.S. in Business Administration from Indiana University of Pennsylvania, MBA with distinction from Gannon University, and completed his doctoral coursework in marketing at Cleveland State University. He is a member of international business honor societies Sigma Beta Delta and Beta Gamma Sigma. He can be followed on Twitter @RfwrightLSL